Figure 2.
Ginsenoside Rg3 inhibits cell invasion and metastatic abilities of ovarian cancer cells. (A and B) The invasion rates of SKOV3 ovarian cancer cells significantly decreased as concentration of ginsenoside Rg3 increased from 50, to 100 and to 200 µg/ml. (C and D) The metastatic rates of SKOV3 ovarian cancer cells significantly decreased as concentration of ginsenoside Rg3 increased from 50, to 100 and to 200 µg/ml. **P<0.01 vs. ovarian cancer cells without ginsenoside Rg3 treatment.